NUELIN DEPOT

Main information

  • Trade name:
  • NUELIN DEPOT 250 mg prolonged-release tablet
  • Dosage:
  • 250 mg
  • Pharmaceutical form:
  • prolonged-release tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • NUELIN DEPOT 250 mg prolonged-release tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Theophylline
  • Product summary:
  • Suitability for use in older adult patients Theophyllinum anhydricum Avoid use in older persons. Narrow therapeutic range. Monitor the drug concentration. Significant adverse effects include gastrointestinal tract symptoms, restlessness, tachycardia and dizziness. Take several interactions into account. Smoking reduces the effect of the drug.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8132
  • Authorization date:
  • 10-08-2006
  • Last update:
  • 26-07-2018